table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 mild to moderate
COVID 19 hospitalizedCOVID-19 mild to moderate
anticoagulant Paranjpe X-COVID-19
anticoagulant, curative dose Bousquet Bousquet COALIZAO ACTION ATTACC, ACTIV-4a, and REMAP-CAP ...
anticoagulant, prophylactic dose Bousquet Bousquet
heparin at therapeutic dose RAPID ...

0 studies excluded by filtering options 2

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons